Interstitial Pneumonitis after Treatment with Bevacizumab and Pegylated Liposomal Doxorubicin in a Patient with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|56|1|69-70

ISSN： 0009-3157

Source： Chemotherapy, Vol.56, Iss.1, 2010-02, pp. : 69-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Recurrent Platinum-Resistant Ovarian Cancer with Pegylated Liposomal Doxorubicin – An Evaluation of the Therapeutic Index with Special Emphasis on Cardiac Toxicity

By  

Chemotherapy, Vol. 55, Iss. 6, 2009-11 ,pp. : 391-398

Karger

Access to resources Recommend Favorite

Interstitial Pneumonitis after Treatment with Pemetrexed: A Rare Event?

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 84-88

Karger

Access to resources Recommend Favorite

Real-World Outcomes of Combination Chemotherapy with Trabectedin plus Pegylated Liposomal Doxorubicin in Patients with Recurrent Ovarian Cancer: A Single-Center Experience

By  

Chemotherapy, Vol. 61, Iss. 3, 2016-01 ,pp. : 122-126

Karger

Access to resources Recommend Favorite

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

By  

Chemotherapy, Vol. 55, Iss. 6, 2009-12 ,pp. : 441-445

Karger

Access to resources Recommend Favorite

Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer

By  

Chemotherapy, Vol. 57, Iss. 6, 2012-01 ,pp. : 468-487

Karger

Access to resources Recommend Favorite